SRY Labs
Finnrick has tested 117 samples from SRY Labs across 11 products.
Finnrick Vendor Profile
to
SRY Labs
Tracking 11 products
117 total samples tested
Last test 25 Mar 2026
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Semaglutide | 4 | 29 Jun 2025 | 15 Jan 2026 | |||||
| Cagrilintide | 7 | 20 Apr 2025 | 13 Mar 2026 | |||||
| Sermorelin | 3 | 20 Apr 2025 | 6 Mar 2026 | |||||
| Tirzepatide | 33 | 15 May 2025 | 25 Mar 2026 | |||||
| BPC-157 | 7 | 17 May 2025 | 6 Nov 2025 | |||||
| CJC-1295 | 4 | 10 Jun 2025 | 21 Aug 2025 | |||||
| GHK-Cu | 7 | 10 Sep 2025 | 2 Feb 2026 | |||||
| PT-141 | 2 | 26 Jun 2025 | 29 Jun 2025 | |||||
| Retatrutide | 30 | 20 Apr 2025 | 25 Mar 2026 | |||||
| TB-500 | 8 | 16 May 2025 | 30 Jan 2026 | |||||
| Tesamorelin | 12 | 27 Jun 2025 | 2 Mar 2026 | |||||
The SRY Labs samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
4.8
Based on 9 overall satisfaction reports
Ease of Purchase4.4(9)
Payment Methods4.3(9)
Delivery Speed4.7(9)
Packaging Quality4.6(9)
Customer Service5.0(1)
People who submitted test requests to Finnrick gave SRY Labs an average satisfaction rating of 4.8 out of 5 across 9 reports associated with samples received and tested by Finnrick. Customers rated payment methods (4.3/5) comparatively lower.
Most recent SRY Labs tests
Samples are tested in commercial labs
117
tests
11
products
Scores
AVGMINMAX
First
20 Apr 2025
Last
25 Mar 2026
| Quantity | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Batch | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 25 Mar 2026 | Retatrutide | View | 10mg | (no batch claim) | 11.3mg | +13.0% | 99.70% | n/a | (no batch ID) | No Label / Silver Crimp / White Cap | Lab G | Public | |
| 25 Mar 2026 | Tirzepatide | View | 10mg | (no batch claim) | 10.3mg | +3.0% | 99.70% | n/a | (no batch ID) | No Label / Silver Crimp / Green Cap | Lab G | Public | |
| 19 Mar 2026 | Retatrutide | View | 5mg | (no batch claim) | 4.2mg | -16.0% | 99.90% | n/a | (no batch ID) | White Label / Silver Crimp / Clear Cap | Lab E | Public | |
| 13 Mar 2026 | Cagrilintide | View | 10mg | 10.7mg | 10.5mg | -2.3% | 99.70% | n/a | H20830825 | No Label / Silver Crimp / White Cap | Lab G | Public | |
| 6 Mar 2026 | Sermorelin | View | 10mg | (no batch claim) | 8.98mg | -10.2% | 98.40% | n/a | (no batch ID) | White Label / Silver Crimp / Gray Cap | Lab E | Public | |
| 2 Mar 2026 | Tesamorelin | View | 5mg | ⚠️ Sample does not contain Tesamorelin | n/a | 2025 | No Label / Silver Crimp / Clear Blue Cap | Lab E | Public | ||||
| 2 Mar 2026 | Tirzepatide | View | 30mg | (no batch claim) | 32.3mg | +7.7% | 99.90% | below LOQ | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab E | Public | |